Nucleic Acids Research Acceptance Rate

The 2024 JIF was unchanged from 15 in 2023 to 13.1 in 2024, which is the useful read after the pandemic-era spike. NAR has normalized back into a very strong, stable upper tier rather than collapsing after the temporary citation surge.

For NAR, the acceptance-rate query is really a proxy for two harder questions:

1. Will this paper survive editorial triage?

1. Is the contribution the kind of thing NAR readers keep citing for years?

That is why guessed percentages are not very useful here.

What the query does tell you:

• NAR is selective enough that broad descriptive studies get cut quickly

• editorial speed means weak positioning is exposed early

• article type matters a lot because resources, methods, and research articles behave differently

What it does not tell you:

• how the Database Issue and Web Server Issue differ from standard research submissions

• how much faster resource papers are screened than broad research papers

• whether the manuscript is failing on scope, mechanism, or utility

The official scope and the handling pattern point to a narrow editorial logic:

1. Does the paper deliver deep molecular mechanism or a clearly durable resource?

1. Is the contribution specific to nucleic-acid biology rather than generally molecular?

1. For methods or resources, is the community value obvious rather than hypothetical?

1. For research articles, is the manuscript more than descriptive?

NAR is one of the journals where "useful but broad" is often not enough. The bar is sharper than that.

Three patterns appear again and again with NAR-targeting manuscripts.

The paper is descriptive when it needs to be mechanistic. A genomics or RNA paper may be clean, data-rich, and interesting, but if the manuscript stops at association, cataloging, or broad profiling without a sharper mechanistic claim, the fit becomes fragile.

The tool or resource is real but not clearly indispensable. NAR has a long history of papers that become field infrastructure. That raises the bar. A database or software resource that is only incrementally different from existing tools is hard to justify here.

The manuscript is broad when the journal wants focus. We repeatedly see papers with ambitious scope but diluted claims. NAR tends to reward sharper, more defensible framing rather than wider but looser storytelling.

This is where fast triage matters. SciRev community handling data still points to very short immediate-rejection times, which matches what authors experience in practice.

For NAR, the better decision question is:

Is this manuscript either mechanistically sharp enough or useful enough that the journal's editorial team can justify sending it to review quickly?

If yes, the missing public acceptance rate is not a blocker. If no, the rate would not help anyway.

The honest answer is that NAR does not publish a clean live public acceptance rate.

The useful answer is:

• the journal is clearly selective

• the current editorial timing confirms very fast triage

• authors should optimize for mechanism, utility, and tight framing rather than for any guessed percentage

If you want a reviewer-style read on whether the manuscript behaves like a real NAR paper before upload, a NAR submission readiness check is the best next step.

NAR's current author guidance distinguishes standard research, methods, database, and web-server work. Each route has a different information-gain test, so a single acceptance estimate would hide the decision an author actually needs to make.

The official instructions also require access to underlying data at submission and a graphical abstract for all article types. Those are current, controllable gates. Recheck the annual issue-specific instructions when targeting the Database or Web Server issues.

For standard routes, the current author guidelines say the text abstract must not exceed 200 words and must use a single paragraph. Database and Web Server submissions have route-specific instructions, so verify those separately.

Submit through the current NAR online submission route linked from Oxford Academic's author guidance.

Evidence basis: This selectivity guide was checked against current NAR author guidance, scope, and journal metrics. NAR does not publish a live acceptance rate on the pages reviewed, and this route test cannot predict an individual decision.